FibroBiologics, Inc. Common Stock
Financial ratios & Valuation

Historical Multiples (2020 – 2023)

2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-217.81-597.67-184.63-57.35N/A-391.15
Price/Sales ratio
N/AN/AN/AN/AN/AN/A
Price/Book Value ratio
N/A-732.96-236.61754.60N/A-484.78
Price/Cash Flow ratio
-217.81-670.58-232.54-147.71N/A-451.56
Price/Free Cash Flow ratio
-217.81-670.58-232.54-137.11N/A-451.56
Price/Earnings Growth ratio
N/A9.55-0.80-0.21N/A4.37
Dividend Yield
N/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/A
Effective Tax Rate
N/AN/AN/AN/AN/AN/A
Return on Assets
N/A-338.03%-106.15%-139.45%N/A-222.09%
Return On Equity
N/A122.63%128.15%-1315.64%N/A125.39%
Return on Capital Employed
N/A122.32%198.62%-336.95%N/A160.47%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/A
Quick Ratio
N/A0.260.371.00N/A0.31
Cash ratio
N/A0.230.320.99N/A0.27
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/A1.91K1.15KN/A957.15
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/A3.251.12N/AN/A2.19
Debt Equity Ratio
N/A-1.18-1.36N/AN/A-1.27
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
N/A6.483.74N/AN/A5.11
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/A-0.92-0.74N/AN/A-0.83
Company Equity Multiplier
N/A-0.36-1.209.43N/A-0.78
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1111.07N/A1
Cash Flow Coverage Ratio
N/A-0.92-0.74N/AN/A-0.83
Short Term Coverage Ratio
N/A-0.92-0.74N/AN/A-0.83
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/A